Abstract
Ribavirin (CAS 66510-90-5) associated to peginterferon (CAS 99210-65-8) is the current
Standard treatment for chronic hepatitis C. Exposure to ribavirin influences the virological
response and anemia. Therefore monitoring plasma concentration of ribavirin is a useful
tool for individualizing ribavirin dosing regimens. Ribavirin is a substrate of several
nucleoside transporters that play a role in its distribution in erythrocytes. After
blood sampling, it is essential to limit this mechanism. The aim of this study was
to evaluate the influence of temperature and time on ribavirin plasma concentrations.
Two blood samples, collected in EDTA tubes, were taken at the same time from 23 patients.
One sample was conserved on ice whereas the second one was kept at room temperature
during transport to the laboratory. Upon receipt at the laboratory and at different
times post-reception (from 1 to 3 h), 1.5 mL of blood from each sample was centrifuged
to obtain plasma that was then stored at −20 °C until assay. Samples were maintained
in the same conditions as during transport for the 3 h. Plasma ribavirin was analysed
using an HPLC-UV system.
The results showed that mean loss of ribavirin concentration, for samples kept on
ice as well as at room temperature, was less than 3%, 9% and 13% after 1, 2 and 3
h, respectively. These results suggest that blood samples for ribavirin analysis can
be sent at room temperature within a period of 2 h between sampling and centrifugation.
Key words
Antiviral drugs - CAS 66510-90-5 - High-performance liquid chromatography - Ribavirin
- Therapeutic drug monitoring
